kabutan

Fuso Pharmaceutical Industries,Ltd.(4538) Summary

4538
TSE Prime
Fuso Pharmaceutical Industries,Ltd.
2,152
JPY
-10
(-0.46%)
Dec 5, 12:46 pm JST
13.87
USD
Dec 4, 10:46 pm EST
Result
PTS
outside of trading hours
2,159
Dec 5, 10:04 am JST
Summary Chart Historical News Financial Result
PER
7.9
PBR
0.54
Yield
4.18%
Margin Trading Ratio
22.59
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
2,161 JPY 13.93 USD
Previous Close Dec 4
2,162 JPY 13.91 USD
High Dec 5, 9:00 am
2,161 JPY 13.93 USD
Low Dec 5, 12:38 pm
2,149 JPY 13.85 USD
Volume
7,800
Trading Value
0.02B JPY 0.11M USD
VWAP
2153.39 JPY 13.89 USD
Minimum Trading Value
215,200 JPY 1,387 USD
Market Cap
0.02T JPY 0.13B USD
Number of Trades
37
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
85
1-Year High Feb 10, 2025
818
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 8,200 21,900 2.67
Nov 21, 2025 7,500 24,300 3.24
Nov 14, 2025 6,100 24,300 3.98
Nov 7, 2025 4,300 25,700 5.98
Oct 31, 2025 4,500 24,300 5.40
Company Profile
Fuso Pharmaceutical Industries, Ltd. is a leading manufacturer of artificial kidney dialysis solutions and holds a high market share in blood-related pharmaceuticals. The company also produces medical devices and generic drugs.
Sector
Pharmaceuticals
Fuso Pharmaceutical Industries, Ltd. primarily engages in the manufacture and sale of medical pharmaceuticals and medical equipment. In the field of medical pharmaceuticals, the company focuses on the production and distribution of injectable solutions, particularly infusion fluids, and artificial kidney dialysis agents. Additionally, the company undertakes contract manufacturing of pharmaceuticals and develops generic drugs. Beyond its pharmaceutical operations, Fuso has established a presence in the real estate sector through property leasing. By encompassing a wide range of activities from manufacturing to sales, primarily in the medical field, Fuso has built a diversified revenue structure.